An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States

Introduction The treatment with tyrosine kinase inhibitors (TKIs) has drastically improved the outcome of chronic myeloid leukemia (CML) patients. This study was conducted to examine the risk of secondary cancers (SCs) in the CML patients who were diagnosed and treated in the TKI era in the United S...

Full description

Bibliographic Details
Main Authors: Vivek Kumar, Mohit Garg, Neha Chaudhary, Abhinav Binod Chandra
Format: Article
Language:English
Published: PeerJ Inc. 2018-02-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/4342.pdf